ScottDavidSolomonMD
Cardiology • Boston, MAProfessor, Medicine-Brigham & Women's Hospital, Harvard Medical School
Dr. Solomon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# PBB1
Boston, MA 02115Phone+1 617-732-7182Fax+1 857-307-0899
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1989 - 1992- Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
Harvard Medical SchoolClass of 1986
Certifications & Licensure
MA State Medical License 1988 - 2025- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Hispanic Community Health Study / Study of Latinos Start of enrollment: 2006 Jan 01
- INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure Start of enrollment: 2016 Aug 01
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. Start of enrollment: 2021 Mar 20
Publications & Presentations
PubMed
- 59 citationsAnthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.Jawad H Butt, Mark C Petrie, Pardeep S Jhund, Naveed Sattar, Akshay S Desai
European Heart Journal. 2023-04-01 - 287 citationsBody Mass Index and Prognosis in Patients With Chronic Heart Failure Insights From the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity...Satish Kenchaiah, Stuart J. Pocock, Duolao Wang, Peter V. Finn, Leonardo A. M. Zornoff
Circulation. 2007-08-07 - 2 citationsFinerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes.Muthiah Vaduganathan, Gerasimos Filippatos, Brian L Claggett, Akshay S Desai, Pardeep S Jhund
Nature Medicine. 2024-09-01
Journal Articles
- Mini Focus on Diabetes Original Investigation Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic RiskNora Franceschini, Amil Shah, Calum A MacRae, Sara B Seidelmann, Scott D Solomon, Susan Cheng, ScienceDirect
- Growth Differentiation Factor‐15 Is Not Modified by sacubitril/valsartan and Is an Independent Marker of Risk in Patients with Heart Failure and Reduced Ejection Fract...Milton Packer, Scott D Solomon, Michael R Zile, European Journal of Heart Failure
- Clinical Research Vaccination Trends in Patients with Heart Failure: Insights from Get with the Guidelines–Heart FailureAdam D DeVore, Adrian F Hernandez, Scott D Solomon, Orly Vardeny, Ankeet S Bhatt, Gregg C Fonarow, Robert J Mentz, Clyde W Yancy, Ileana L Pina, ScienceDirect
- Join now to see all
Lectures
- Heart Failure with Preserved Ejection Fraction: From Mechanisms to TherapiesScientific Sessions 2007, Orlando, Florida, USA
- Heart Failure with Preserved Ejection Fraction: From Mechanisms to TherapiesEuropean Society of Cardiology, ESC Congress 2012, Munich, Germany
- Heart Failure with Preserved Ejection Fraction: From Mechanisms to TherapiesEuropean League Against Rheumatism, Annual European Congress of Rheumatology 2008, Paris, France
- Join now to see all
Press Mentions
Estimated Long-Term Benefits of Finerenone in Heart FailureSeptember 27th, 2024- Clinical Trials Observed Cardiovascular Death and Worsening Heart Failure Reduced by FinerenoneSeptember 4th, 2024
- Heart Drug Improved Exercise Tolerance in Clinical Trial of Patients with Hypertrophic Obstructive CardiomyopathySeptember 4th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
